Theralase Technologies Inc. | Balance Sheet
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,768.30
1,922.50
4,340.90
2,970.20
253.90
1,033.70
Total Accounts Receivable
310.70
630.10
1,179.80
1,200.10
1,164.50
790.50
Inventories
190.40
295.60
913.50
1,215.80
1,046.50
864.30
Other Current Assets
58.10
574.90
159.10
231.10
77.80
56.40
Total Current Assets
2,327.50
3,423.00
6,593.30
5,617.10
2,542.60
2,744.80
Net Property, Plant & Equipment
221.50
270.80
405.20
569.70
744.10
672.70
Long-Term Note Receivable
23.50
29.00
30.30
-
-
112
Intangible Assets
112.30
94.30
73.30
54.00
35.90
18
Total Assets
2,684.90
3,817.10
7,102.10
6,240.80
3,322.70
3,564.40
ST Debt & Current Portion LT Debt
28.70
-
-
-
-
Accounts Payable
572.40
289.30
390.40
311.90
1,089.30
Other Current Liabilities
312.10
222.40
395.30
237.80
187.80
Total Current Liabilities
913.30
511.80
785.70
549.70
1,277.10
Long-Term Debt
0.20
-
-
-
-
Other Liabilities
7.60
-
-
-
-
Total Liabilities
921.00
511.80
785.70
549.70
1,277.10
Common Equity (Total)
1,763.90
3,305.30
6,316.50
5,691.00
2,045.60
Total Shareholders' Equity
1,763.90
3,305.30
6,316.50
5,691.00
2,045.60
Total Equity
1,763.90
3,305.30
6,316.50
5,691.00
2,045.60
Liabilities & Shareholders' Equity
2,684.90
3,817.10
7,102.10
6,240.80
3,322.70
About Theralase Technologies
View Profile
